Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Revised SOPs for Tablet Manufacturing V2.0

Tablets: SOP for Disintegration Testing for Immediate Release Tablets – V 2.0

Posted on By

To outline the procedure for performing disintegration testing of immediate release tablets, ensuring that the tablets break down into smaller particles as required by pharmacopoeial standards.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Assay Method Validation for Enteric-Coated Tablets – V 2.0

Posted on By

To provide a standardized procedure for validating assay methods used for determining the active pharmaceutical ingredient (API) content in enteric-coated tablets.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Dissolution Profile Testing for Sustained Release Tablets – V 2.0

Posted on By

To outline the procedure for conducting dissolution profile testing for sustained release tablets, ensuring that the tablets release the active pharmaceutical ingredient (API) at a controlled and consistent rate over time.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Hardness Testing of Chewable Tablets – V 2.0

Posted on By

To define the procedure for conducting hardness testing of chewable tablets to ensure that the tablets meet the required mechanical strength and are capable of withstanding physical stress during handling and packaging.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Weight Variation Testing for Tablets – V 2.0

Posted on By

To outline the procedure for performing weight variation testing on tablets, ensuring that the tablets conform to the established weight limits set by regulatory standards and internal specifications.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Coating Thickness Measurement in Sugar-Coated Tablets – V 2.0

Posted on By

To provide a standardized procedure for measuring the coating thickness of sugar-coated tablets, ensuring that the coating is within the required specifications for uniformity and quality.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for pH Stability Testing for Enteric-Coated Tablets – V 2.0

Posted on By

To establish a procedure for pH stability testing of enteric-coated tablets, ensuring that the tablets maintain their intended performance and dissolution characteristics across a range of pH values over time.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Microbial Limit Testing for Dispersible Tablets – V 2.0

Posted on By

To establish a procedure for microbial limit testing of dispersible tablets, ensuring that the tablets meet the required microbiological standards for safe consumption.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Related Substance Testing for Extended Release Tablets – V 2.0

Posted on By

To define the procedure for testing related substances in extended release tablets, ensuring that the content of related substances in the tablets is within the specified limits, thereby ensuring product quality and compliance with regulatory standards.

Click to read the full article.

Tablet Manufacturing V2.0

Tablets: SOP for Residual Solvent Testing in Film-Coated Tablets – V 2.0

Posted on By

To outline the procedure for residual solvent testing in film-coated tablets, ensuring that the levels of residual solvents do not exceed the limits set by regulatory standards and internal specifications, ensuring product safety and compliance.

Click to read the full article.

Tablet Manufacturing V2.0

Posts pagination

Previous 1 … 7 8 9 … 25 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme